查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1628801

欧洲泡壳包装：市场占有率分析、产业趋势、成长预测（2025-2030）

Europe Blister Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

欧洲泡壳包装市场预计在预测期内复合年增长率为 6.45%

欧洲吸塑包装-市场-IMG1

主要亮点

  • 不断上升的发病率和政府对假药的严格监管正在增加製药公司生产药品的压力。泡壳包装为钞票认证系统等防伪系统提供了有效的方法。
  • 英国製药业是该国研究和创新领域的主要企业之一。该行业在研发上花费了数十亿美元，并僱用了大量高技能的研发工作。英国製药工业协会 (ABPI) 的数据显示，在製药业直接就业的 73,000 名员工中，有 23,000 人从事研发工作。
  • 大量的投资和技术纯熟劳工率表明英国正在如何建立药品和未来药品的管道。这些持续的投资预计将为该国泡壳包装的成长提供巨大的机会。
  • 由于其在整个供应链中提供个人安全的潜力，泡壳中越来越多地使用创新技术，例如在包装外部贴上标籤的 RFID（无线射频识别标籤）。只有在仅分配一颗胶囊或锭剂或保护屏障被破坏并施用时，才会发生泡壳中样品的污染。
  • 此外，这次疫情爆发也引发了世界各地针对 COVID-19 疫苗开发的研究。例如，医疗保健巨头强生公司于 2020 年 9 月开始临床试验，并透过美国卫生与公共服务部获得了约 5 亿美元的合作资金。
  • 匹兹堡大学和休士顿贝勒医学院的研究人员开发的一种实验性疫苗也在等待食品药物管理局的批准，开始在人体中进行测试。如果研究人员开发的这些疫苗成功，就可以大规模生产，这可能会进一步增加对液体瓶的需求。

欧洲泡壳包装市场趋势

药品预计将显着成长

  • 製药业对泡壳包装解决方案提出了多种要求，包括与外部环境隔离、成本效益、高防护性、易于处理以及保存药效等。这些包装特别适合满足严格的法规，并因其保护性能、成本效益、适应性以及製药和包装行业的需求而受到重视。
  • 当药物采用泡壳包装时，消费者知道他们的药物和剂量，从而提高用药依从性。泡壳的单位剂量特征降低了错误剂量的风险。
  • 零售层面的处方药製备对于製药技术人员和药剂师来说是一个挑战。在超级市场和药局的开放环境中给药可能会对敏感药物在容器之间转移时产生不利影响。泡壳包装可以确保直接配送给客户的过程。
  • 虽然保护产品完整性仍然是药品包装的首要目标，但包装产业的所有领域都在继续努力降低包装过程中的成本。例如，Amcor 的 Polybar 阻隔薄膜系列涵盖广泛的防潮阻隔性，具有出色的抗压性能，可确保为锭剂和胶囊等製药应用提供最佳保护。我们使用 Aclar、COC、PE、PVC 和 PVdc 等材料。
  • 此外，COVID-19 的爆发扩大了泡壳包装的市场。 2019年10月，乌克兰製药公司Darnitsa通过了COVID-19治疗通讯协定中实验药物的国家註册。
  • 该地区多个国家已禁止出口已显示有效对抗冠状病毒感染的药品，首先满足国内需求非常重要。 Darnica 製药公司已通过了羟氯喹是一种包含在 COVID-19 治疗方案中的实验药物。

独联体国家预计将显着成长

  • 在独联体国家中，俄罗斯预计将占有很大份额。身为独立国协（CIS）成员，俄罗斯製药业是智慧财产权（IP）管理最复杂的产业之一。
  • 俄罗斯的药品生产正在显着成长。据俄罗斯工贸部透露，俄罗斯政府预计2020年国内药品产量将增加20%，并在俄罗斯政府负责医药产业的发展。
  • 该部长表示，预期成长与 2020 年前四个月的成长相当，主要是由于该国多个新生产设施的试运行。
  • 然而，俄罗斯政府制定了新策略，即「製药2030」国家计划，预计製药业将出现正面趋势。莫斯科地区发展公司 (MRDC) 文件描述了过去 10 年的成就、对新项目的期望以及有前景的医药投资领域和地点。
  • 此外，据MRDC称，近期俄罗斯将开始实施医药工业发展国家战略「Pharma 2030」。该战略为重点产业提供了方向，国家支持机制将刺激重点产业的发展。
  • 国家「医药2020」计画有力地推动了医疗和製药业的发展，特别是在实施初期。行业相关人员可以期待新的国家计划的良好开端，这些计划预计将促进独联体地区的市场成长。

欧洲泡壳包装产业概况

欧洲泡壳包装市场较为分散。伙伴关係、併购和收购已成为市场上供应商生产最终用户行业可接受的产品的重要策略，其中包装材料经过严格的品质测试，以确保它们不会污染内容物并影响健康。维持原料的持续流动仍是促进伙伴关係的挑战。市场主要参与者包括Amcor Ltd、Westrock Company、Sonoco Products Company、Constantia Flexibles GmbH、Honeywell International Inc.等。

  • 2021 年 4 月 - Amcor 宣布对可回收聚乙烯基热成型泡壳包装进行客户试验。这种新包装旨在满足高度专业化和监管的药品包装的严格要求，为最受欢迎的医疗保健包装类型创造更永续的选择。与市场上的替代包装相比，这项创新还可以减少高达 70% 的碳足迹。
  • 2021 年 7 月 -Honeywell与主要企业的技术主导医疗保健改善公司 Premier 宣布建立新的商业关係，重点扩大国内丁腈检查手套的生产。新的合作伙伴关係预计仅第一年就将生产至少 7.5 亿隻国产丁腈检查手套。

其他好处：

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

目录

第一章简介

  • 研究假设和市场定义
  • 调查范围

第二章调查方法

第三章执行摘要

第四章市场洞察

  • 市场概况
  • 市场驱动因素
    • 老年人口增加和疾病传播
    • 产品创新，例如相对便宜的小型化
  • 市场挑战
    • 法规的动态性和缺乏处理重负载的能力
  • 产业吸引力－波特五力分析
    • 供应商的议价能力
    • 消费者议价能力
    • 新进入者的威胁
    • 竞争公司之间的敌对关係
    • 替代品的威胁
  • 评估 COVID-19 对泡壳包装市场的影响

第五章欧洲泡壳包装市场区隔

  • 按流程
    • 热成型
    • 冷成型
  • 按材质
    • 塑胶薄膜
    • 纸板
    • 铝
    • 其他材料
  • 按最终用户产业
    • 消费品
    • 药品
    • 工业的
    • 其他最终用户产业
  • 按国家/地区
    • 独联体国家
    • 英国
    • 德国
    • 法国
    • 其他欧洲国家

第六章 竞争状况

  • 公司简介
    • Amcor PLC
    • Westrock Company
    • Constantia Flexibles GmbH
    • Sonoco Products Company
    • Klockner Pentaplast Group
    • EI Du Pont De Nemours and Company
    • Honeywell International Inc.
    • The Dow Chemical Company
    • Tekni-Plex Inc.

第七章 投资分析

第八章市场的未来

简介目录
Product Code: 54578

The Europe Blister Packaging Market is expected to register a CAGR of 6.45% during the forecast period.

Europe Blister Packaging - Market - IMG1

Key Highlights

  • Growing pressure on pharmaceutical companies to manufacture medicines that are different in packaging and hard to imitate, surpassing the basic need of keeping it useful for the purpose it was produced, for it to be made available for patients, due to growth in diseases and stringent government regulations against counterfeit drugs, are among the significant factors propelling the market. Blister packaging provides an efficient method of anti-counterfeit systems, like banknote authentication systems and others.
  • The UK pharmaceutical industry is one of the major players in the research and innovation of the country. The industry contributes billions on R&D and employs vast numbers for highly-skilled R&D roles. According to the Association of the British Pharmaceutical Industry (ABPI), 23,000 people work in R&D out of 73,000 people employed directly by the pharmaceutical industry.
  • The massive investments and the proportion of skilled workers employed show how Britain is building up the pipeline of medicines and future drugs. These ongoing investments are expected to provide an excellent opportunity for the growth of blister packaging in the country.
  • The use of innovative technologies in blisters, such as RFID (radio frequency identification tags), deployed with a seal applied outside the packaging, is increasing due to the potential to offer individual security throughout supply chains. Contamination of samples in blisters only occurs when a single capsule or tablet is dispensed or administered when the protective barrier is broken.
  • Furthermore, the outbreak has increased the research across the world for developing a vaccine for COVID-19. For instance, the healthcare giant, Johnson & Johnson, started clinical trials in September 2020 and has received a nearly USD 500 million partnership via a US Department of Health and Human Services division.
  • Also, experimental vaccines developed by researchers at the University of Pittsburgh and Baylor College of Medicine in Houston are also waiting for permission from the Food and Drug Administration to begin testing in people. The success of these vaccines developed by the researchers might follow the large-scale manufacture of them, further driving the demand for liquid bottles.

Europe Blister Packaging Market Trends

Pharmaceutical is Expected to Witness a Significant Growth

  • The pharmaceutical sector poses a different set of demands for blister packaging solutions, concerning insulation from external surroundings, cost-effectiveness, high levels of protection, and the ease of handling and retaining the effectiveness of the medicine.These packs are uniquely suited to meet stringent regulations and are highly valued for protective properties, cost-effectiveness, adaptability, and the pharmaceutical and packaging industry's requirements.
  • When medicines are blister packaged, adherence is improved because consumers can keep track of their medications and dosage. The unit dosage feature of blisters reduces the risk of incorrect dosing.
  • The retail-level preparation of prescription drugs is troubling pharmaceutical technicians or pharmacists. The administration of medicines in the open atmosphere of the supermarket and drug store may negatively affect sensitive medicines when they are transferred from container to container. Blister packaging can guarantee the process of distribution directly to the customer.
  • Protecting product integrity continues to be the primary goal of pharmaceutical packaging, but there is continued work on cost reduction in the packaging process in all areas of the packaging industry. For instance, The Polybar barrier films product families provided by Amcor cover a wide range of moisture barriers whilst also providing good crush resistance to ensure the best protection for pharmaceutical applications such as tablets and capsules. It uses materials such as Aclar, COC, PE, PVC, and PVdc, among others.
  • Further, the outbreak of the COVID-19 has increased the market for blister packaging. In October 2019, the Ukrainian pharmaceutical company Darnitsa passed the state registration for an experimental drug in the treatment protocol for COVID-19.
  • A few countries across the region have banned the export of medicines that have shown efficacy in the fight against coronavirus infection, and first and foremost, meet the domestic demand. The Darnitsa pharmaceutical company passed the state registration for hydroxychloroquine substance - an experimental drug that is included in the treatment protocol for COVID-19.

CIS Countries are Expected to WItness SIgnificant Growth

  • Among the CIS countries, Russia is anticipated to hold a significant share. The pharmaceutical industry in Russia, one of the Commonwealth of Independent States (CIS) countries, can be considered one of the most complex sectors when considering the management of the intellectual property (IP), as it involves complicated legal, regulatory, linguistic, and marketing factors.
  • The country has been witnessing significant growth in drug production. According to the Russian Ministry of Industry and Trade, the Russian government expects a 20% growth of domestic drug production in 2020, which is responsible for developing the pharmaceutical industry in the Russian government.
  • According to the Minister, the expected growth will be comparable to that which was observed in the first four months of 2020 and was mainly due to the commissioning of some new production facilities within the country.
  • However, the Russian government has also prepared a new strategy - the state program Pharma 2030, which should get the pharmaceutical sector's positive trends. The past decade's results, the expectations for the new program, and the promising areas and locations for investments in pharmaceuticals are mentioned in the Moscow Region Development Corporation (MRDC) material.
  • And according to MRDC, in the near future, Russia will start implementing the state strategy of pharmaceutical industry development Pharma 2030. The strategy indicates the main industry directions, the growth of which will be stimulated with the help of the state support mechanisms.
  • The state program of the country Pharma 2020 gave a strong impetus for developing the medical and pharmaceutical sectors, particularly at the initial stage of implementation. Industry players can expect a good start from the new state program, which is anticipated to augment the market growth in the CIS region.

Europe Blister Packaging Industry Overview

The market for Europe Blister Packaging Market is moderately fragmented. Partnership, mergers, and acquisitions have been a significant strategy for the vendors in the market for producing acceptable products in the end-user industry, where packaging materials undergo stringent quality tests not to contaminate the contents impact health. Maintaining a continuous flow of raw materials remain a challenge that prompts partnerships. Some of the major players in the market are Amcor Ltd, Westrock Company, Sonoco Products Company, Constantia Flexibles GmbH, Honeywell International Inc., among others.

  • April 2021 - Amcor announced customer trials for the recyclable Polyethylene-based thermoform blister packaging. The new packaging is designed to meet the stringent requirements of highly specialized and regulated pharmaceutical packaging and creates a more sustainable alternative for the most in-demand healthcare packaging type. This innovation also benefits from up to 70% reduction in its carbon footprint when compared to packaging alternatives on the market.
  • July 2021 - Honeywell and Premier Inc., a leading technology-driven healthcare improvement company, announced a new commercial relationship dedicated to expanding the domestic production of nitrile exam gloves. This new collaboration is expected to produce at least 750 million domestically made nitrile exam gloves in the first year alone.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing geriatric population and prevalence of diseases
    • 4.2.2 Product innovations such as downsizing coupled with relatively low costs
  • 4.3 Market Challenges
    • 4.3.1 Dynamic nature of regulations and inability to support heavy goods
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Intensity of Competitive Rivalry
    • 4.4.5 Threat of Substitutes
  • 4.5 Assessment of the impact of COVID-19 on Blister Packaging Market

5 EUROPE BLISTER PACKAGING MARKET SEGMENTATION

  • 5.1 By Process
    • 5.1.1 Thermoforming
    • 5.1.2 Coldforming
  • 5.2 By Material
    • 5.2.1 Plastic Films
    • 5.2.2 Paper and Paperboard
    • 5.2.3 Aluminum
    • 5.2.4 Other Materials
  • 5.3 By End-User Industry
    • 5.3.1 Consumer Goods
    • 5.3.2 Pharmaceutical
    • 5.3.3 Industrial
    • 5.3.4 Other End-user Industries
  • 5.4 By Country
    • 5.4.1 CIS countries
    • 5.4.2 United Kingdom
    • 5.4.3 Germany
    • 5.4.4 France
    • 5.4.5 Rest of Europe

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Amcor PLC
    • 6.1.2 Westrock Company
    • 6.1.3 Constantia Flexibles GmbH
    • 6.1.4 Sonoco Products Company
    • 6.1.5 Klockner Pentaplast Group
    • 6.1.6 E.I. Du Pont De Nemours and Company
    • 6.1.7 Honeywell International Inc.
    • 6.1.8 The Dow Chemical Company
    • 6.1.9 Tekni-Plex Inc.

7 INVESTMENT ANALYSIS

8 FUTURE OF THE MARKET